Varex Imaging Corporation (VREX)
USD 10.32
(-9.76%)
USD 10.32
(-9.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 32.1 Million USD | -58.37% |
| 2023 | 77.1 Million USD | 52.07% |
| 2022 | 50.7 Million USD | 51.8% |
| 2021 | 33.4 Million USD | 208.09% |
| 2020 | -30.9 Million USD | -476.83% |
| 2019 | 8.2 Million USD | -81.57% |
| 2018 | 44.5 Million USD | -46.83% |
| 2017 | 83.7 Million USD | -23.28% |
| 2016 | 109.1 Million USD | -14.43% |
| 2015 | 127.5 Million USD | -27.56% |
| 2014 | 176 Million USD | 4.27% |
| 2013 | 168.8 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 9.3 Million USD | 20.78% |
| 2024 Q1 | 4.2 Million USD | -82.72% |
| 2024 Q2 | 7.7 Million USD | 83.33% |
| 2023 Q2 | 15.6 Million USD | 218.37% |
| 2023 Q1 | 4.9 Million USD | -68.18% |
| 2023 Q4 | 24.3 Million USD | 0.41% |
| 2023 FY | 77.1 Million USD | 52.07% |
| 2023 Q3 | 24.2 Million USD | 55.13% |
| 2022 Q1 | 14 Million USD | -47.17% |
| 2022 FY | 50.7 Million USD | 51.8% |
| 2022 Q4 | 15.4 Million USD | 6.21% |
| 2022 Q3 | 14.5 Million USD | -45.49% |
| 2022 Q2 | 26.6 Million USD | 90.0% |
| 2021 FY | 33.4 Million USD | 208.09% |
| 2021 Q4 | 26.5 Million USD | 3.11% |
| 2021 Q2 | 15.8 Million USD | 159.02% |
| 2021 Q3 | 25.7 Million USD | 62.66% |
| 2021 Q1 | 6.1 Million USD | 147.29% |
| 2020 Q1 | 4.6 Million USD | -71.6% |
| 2020 Q3 | -26.8 Million USD | -2014.29% |
| 2020 Q4 | -12.9 Million USD | 51.87% |
| 2020 FY | -30.9 Million USD | -476.83% |
| 2020 Q2 | 1.4 Million USD | -69.57% |
| 2019 Q1 | 10.4 Million USD | 62.5% |
| 2019 FY | 8.2 Million USD | -81.57% |
| 2019 Q4 | 16.2 Million USD | 252.17% |
| 2019 Q3 | 4.6 Million USD | -68.28% |
| 2019 Q2 | 14.5 Million USD | 39.42% |
| 2018 FY | 44.5 Million USD | -46.83% |
| 2018 Q4 | 6.4 Million USD | -12.33% |
| 2018 Q1 | 13.6 Million USD | -49.06% |
| 2018 Q2 | 17.2 Million USD | 26.47% |
| 2018 Q3 | 7.3 Million USD | -57.56% |
| 2017 Q3 | 15.5 Million USD | -34.04% |
| 2017 FY | 83.7 Million USD | -23.28% |
| 2017 Q1 | 18.6 Million USD | -43.64% |
| 2017 Q2 | 23.5 Million USD | 26.34% |
| 2017 Q4 | 26.7 Million USD | 72.26% |
| 2016 Q1 | 22.6 Million USD | -13.08% |
| 2016 Q2 | 25.2 Million USD | 11.5% |
| 2016 Q4 | 33 Million USD | 16.2% |
| 2016 Q3 | 28.4 Million USD | 12.7% |
| 2016 FY | 109.1 Million USD | -14.43% |
| 2015 FY | 127.5 Million USD | -27.56% |
| 2015 Q4 | 26 Million USD | 0.0% |
| 2014 FY | 176 Million USD | 4.27% |
| 2013 FY | 168.8 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 323.522% |
| Cerus Corporation | -30.05 Million USD | 206.811% |
| OrthoPediatrics Corp. | -25.76 Million USD | 224.583% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 402.222% |
| Talis Biomedical Corporation | -66.81 Million USD | 148.043% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 285.592% |
| Inogen, Inc. | -109.38 Million USD | 129.346% |
| Spectral AI, Inc. | -12.98 Million USD | 347.227% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 151.287% |
| CVRx, Inc. | -43.1 Million USD | 174.473% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 1009.864% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 358.288% |
| Orthofix Medical Inc. | -139.11 Million USD | 123.075% |
| Venus Concept Inc. | -28.3 Million USD | 213.392% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 159.414% |
| Bioventus Inc. | -81.72 Million USD | 139.278% |
| BrainsWay Ltd. | -4.92 Million USD | 751.512% |
| Envoy Medical, Inc. | -18.37 Million USD | 274.732% |
| electroCore, Inc. | -18.8 Million USD | 270.699% |
| IceCure Medical Ltd | -15.57 Million USD | 306.086% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 166.21% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 285.893% |
| MaxCyte, Inc. | -48.29 Million USD | 166.461% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 368.501% |
| Nexalin Technology, Inc. | -5.69 Million USD | 663.524% |
| PAVmed Inc | -68.79 Million USD | 146.66% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 156.751% |
| RxSight, Inc. | -50.08 Million USD | 164.091% |
| Sight Sciences, Inc. | -57.27 Million USD | 156.046% |
| SI-BONE, Inc. | -46.93 Million USD | 168.398% |
| TELA Bio, Inc. | -44.07 Million USD | 172.83% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 159.28% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 162.417% |
| LivaNova PLC | -68.49 Million USD | 146.863% |
| 908 Devices Inc. | -42.75 Million USD | 175.074% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 118.513% |
| Nemaura Medical Inc. | -9.59 Million USD | 434.541% |
| NeuroPace, Inc. | -27.17 Million USD | 218.128% |
| LENSAR, Inc. | -12.22 Million USD | 362.491% |
| Apyx Medical Corporation | -17.25 Million USD | 285.99% |
| Cutera, Inc. | -156.23 Million USD | 120.547% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 473.082% |
| BioSig Technologies, Inc. | -28.51 Million USD | 212.584% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 136.628% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 243.01% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 71.217% |
| Axonics, Inc. | -26.05 Million USD | 223.191% |
| Outset Medical, Inc. | -169.77 Million USD | 118.908% |
| IRIDEX Corporation | -10 Million USD | 420.775% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 129.404% |
| IRadimed Corporation | 20.03 Million USD | -60.216% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 489.327% |
| INVO Bioscience, Inc. | -6.76 Million USD | 574.35% |
| Telesis Bio, Inc. | -35.15 Million USD | 191.323% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -124.006% |
| Quipt Home Medical Corp. | 3.91 Million USD | -719.087% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 364.568% |
| Pulmonx Corporation | -61.93 Million USD | 151.829% |
| Dynatronics Corporation | -2.27 Million USD | 1512.201% |
| Modular Medical, Inc. | -17.52 Million USD | 283.125% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 319.277% |
| Semler Scientific, Inc. | 22.25 Million USD | -44.231% |
| InMode Ltd. | 195.66 Million USD | 83.594% |
| Bruker Corporation | 436.9 Million USD | 92.653% |
| Cytosorbents Corporation | -31.2 Million USD | 202.854% |
| DexCom, Inc. | 597.7 Million USD | 94.629% |
| Align Technology, Inc. | 643.33 Million USD | 95.01% |
| Viveve Medical, Inc. | -21.55 Million USD | 248.935% |
| ZimVie Inc. | -30.93 Million USD | 203.753% |
| Movano Inc. | -29.69 Million USD | 208.117% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 215.281% |
| Nexalin Technology, Inc. | -5.69 Million USD | 663.524% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 1009.864% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 113.763% |
| Profound Medical Corp. | -28.61 Million USD | 212.175% |
| Insulet Corporation | 220 Million USD | 85.409% |
| enVVeno Medical Corporation | -25.23 Million USD | 227.189% |
| Surmodics, Inc. | -5.64 Million USD | 668.645% |
| iCAD, Inc. | -7.68 Million USD | 517.48% |
| Nuwellis, Inc. | -17.63 Million USD | 282.076% |
| Biotricity, Inc. | -8.82 Million USD | 463.605% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 125.647% |
| Aethlon Medical, Inc. | -12.63 Million USD | 354.025% |
| InspireMD, Inc. | -21.14 Million USD | 251.823% |
| PAVmed Inc. | -68.79 Million USD | 146.66% |
| BIOLASE, Inc. | -17.93 Million USD | 278.96% |
| Beyond Air, Inc. | -63 Million USD | 150.948% |
| FONAR Corporation | 16.53 Million USD | -94.129% |
| AxoGen, Inc. | -21.46 Million USD | 249.567% |
| Vivani Medical, Inc. | -26.96 Million USD | 219.043% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -77.928% |
| Inari Medical, Inc. | -14.03 Million USD | 328.763% |
| UFP Technologies, Inc. | 57.66 Million USD | 44.333% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 751.433% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 609.058% |
| Tenon Medical, Inc. | -15.72 Million USD | 304.108% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 529.489% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 175.165% |
| AdaptHealth Corp. | -598.4 Million USD | 105.364% |
| Sintx Technologies, Inc. | -13.35 Million USD | 340.305% |
| NanoVibronix, Inc. | -3.43 Million USD | 1034.226% |
| Quanterix Corporation | -49.7 Million USD | 164.586% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 364.568% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 8503.141% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 109.597% |
| TransMedics Group, Inc. | -28.72 Million USD | 211.742% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 235.948% |
| NeuroMetrix, Inc. | -7.15 Million USD | 548.856% |
| Hyperfine, Inc. | -48.11 Million USD | 166.715% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 149.365% |
| Biomerica, Inc. | -6.36 Million USD | 604.162% |
| Bone Biologics Corporation | -9.42 Million USD | 440.464% |
| AVITA Medical, Inc. | -40.4 Million USD | 179.451% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 411.311% |
| Silk Road Medical, Inc | -59.27 Million USD | 154.158% |